About Jeff Sabados
Form D filings for Hubble Therapeutics in 2024 list Jeff Sabados as chief executive officer and director.
Jeff Sabados first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Jeff Sabados in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jeff Sabados works with at each company, as listed on that company's latest Form D.
Hubble Therapeutics, LLC · Form D, Oct 21, 2024
SG
Sam Goldberger
Director
GK
Greg Keenan
Director